Below is a representative list of partnering companies for the 2020 Asia International Conference:
A*START: ETC/D3 A. Menarini Asia-Pacific Holdings AbbVie AbClon Accurna Aceras Life Sciences Adare Pharmaceuticals Aeterna Zentaris Gmbh Affilogic Ajinomoto Co. AlphaCent GmbH AMAG Pharmaceuticals Amgen Amgen Business Development Amgen Strategy Commercialization & Innovation Anima Biotech Anthos Therapeutics Apellis Pharmaceuticals API Co. Arbor Pharmaceuticals Asahi Kasei Pharma Corporation Asset Management Ventures Astellas Pharma Astellas Venture Management Aurinia Pharmaceuticals Aurora Partners K.K. Ayala Pharma BBC World Turkish Berlin Partner for Business and Technology BioCentury BioInnovation Capital BioInvent International AB BioLite, Inc. Bionoxx Biorchestra Biotome Boston Pharmaceuticals Caladrius Biosciences CDIB Capital Healthcare Ventures CellSeed Champions Oncology Chaperone Investment Chia Tai Tianqing Pharmaceutical Group Co. Chiome Bioscience Copenhagen Capacity Covance Japan Co. CureBio Co. Daewoong pharmaceuticals Co. Daiichi Sankyo Co. Delta-Fly Pharma Diurnal Dot World Co. Dr. Reddy's Laboratories Dr. Wild & Co. DrugCendR Hong Kong Eddingpharm Eight Roads Ventures Japan Eisai Co. Eli Lilly and Company Elixiron Immunotherapeutics Eloxx Pharmaceuticals Engine Biosciences Engrail Therapeutics Entera Health Ethypharm Evaluate Japan Experimental Drug Development Centre, Singapore First Republic Bank Garvan Insitute of Medical Research GC Pharma Gemseki Genopole Genovior Biotech Corporation GI Innovation GIP Genopole GNT Pharma Golden Biotechnology Golden Helix Great Bay Bio Limited Hannol Ventures Hanyang University Harbin Pharma Heartseed Hotung International Company IH BIO Ildong Pharmaceutical Illingworth Research Group | Immunic AG Innovation Network Corporation of Japan IQVIA Services Japan K.K. Italfarmaco Itochu JAFCO JOGO Health JSR Life Sciences Kaken Pharmaceutical Kine Sciences Kissei Pharmaceutical Kleiner, Perkins, Caufield & Byers LG Chem Liberi Group Liminal BioSciences Lineage Cell Therapeutics M Bio Technology Mammoth Biosciences Merck Middlemore Clinical Trials Mission BioCapital Mitsubishi UFJ Capital Mitsui Global Investment Momentum Biotech Momotaro-Gene Monocl AB MSD K.K. MSQ Ventures NeuroVis Newron Pharmaceuticals Nimble Nippon Boehringer Ingelheim Co. Nissan Chemical Corporation Nordic Bioscience Clinical Development Novelty Nobility Novotech CRO ONC OSE Immunotherapeutics Otsuka Pharmacautical Co. Perception Neuroscience pH pharma Co. PharmaResearch Products Pharmstandard Ventures Phenex Pharmaceuticals AG Pierre Fabre Premir Partners Protalix ProxyKine Quark Biosciences Questel Japan Co. Rakuten Medical Japan Remiges Ventures Rockwell Medical RubrYc Therapeutics S&P Global Market Intelligence Sage Therapeutics Samsung Biologics Sanofi Sant-Yalla Sanwa Kagaku Kenkyusho Co. Servier Shaperon Shinsei Capital Partners SmartAnalyst India Socium STADA Pharmaceuticals Stelexis Therapeutics Tad International TAGCyx Biotechnologies Takeda Pharmaceutical Teijin Pharma Limited Teon Therapeutics ThinkCyte Tian Shing Trading Co. Toray Industries Transcure Bioservices Trinity Innovation Investment Management twoXAR Univercells University of Texas, MD Anderson Cancer Center VelocityHealth Securities Verastem Oncology Virometix AG W Global Capital Limited Whan In Pharm Co. Y-Biologics Zentiva Zeria Pharmaceutical Zoetis |
Partnering Investors
Aceras Life Sciences
Asset Management Ventures
BioInnovation Capital
Chaperone Investment
Eight Roads Ventures Japan
First Republic Bank
Hannol Ventures
Harbin Pharma
JAFCO
Mitsubishi UFJ Capital
Mitsui Global Investment
Momentum Biotech
MSQ Ventures
Otsuka Pharmacautical Co.
Premir Partners
Shinsei Capital Partners
W Global Capital
*As of 2/14/2020